I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Coma scales are used to quantitatively evaluate patients with consciousness disorders, which can be easily accomplished by all health-care providers with high repeatability. The Glasgow Coma Scale (GCS) was first introduced in 1974 to assess coma and impaired consciousness in traumatic brain injury (TBI).\[[@ref1]\] Although the GCS is widely applied in daily clinical practice, several limitations have been identified, such as an inability to accurately assess intubated patients and difficulty in assessing aphasic patients or aphonic patients due to the requirement of a verbal component. In addition, difficulty in assessment was noted in patients who have facial or ocular injuries that impede eye evaluation. Therefore, some researchers resorted to simplified coma scales, which excluded the verbal and eye-moving evaluation. In addition, lesser items may have less intra- and inter-rater reliability variation and better accuracy than the GCS. In 2003, Healey *et al*.\[[@ref2]\] showed that the GCS motor component (GCS-M) contains virtually all the information of the GCS itself in predicting the outcome of TBI with intubation. Derived from the 6 points of the GCS-M scores, Gill *et al*.\[[@ref3]\] came up with a simpler three-level assessment tool, named Simplified Motor Score (SMS) in 2005. In 2013, one meta-analysis involving 102,132 patients showed that SMS predicted outcomes with similar accuracy to the GCS in TBI.\[[@ref4]\] Recently, one study showed that, in cases where the full GCS was difficult to assess, the GCS-M and SMS could be used safely to predict outcome in patients with TBI.\[[@ref5]\] However, it remains undetermined whether these findings can be generally applied to intubated patients and coma patients due to other diseases. Here, we attempted to verify that the GCS-M or the SMS could be reliably used to assess the prognosis in acute severe cerebral vascular disease patients.

M[ETHODS]{.smallcaps} {#sec1-2}
=====================

Ethical approval {#sec2-1}
----------------

The study was conducted in accordance with the *Declaration of Helsinki* and approved by the Ethics Committee of Xuanwu Hospital, Capital Medical University, Beijing (No. \[2008\] 03). As a retrospective study, this study was exempt from the informed consent from patients.

Study population {#sec2-2}
----------------

Acute severe cerebral vascular disease patients admitted to the Xuanwu Hospital Neurointensive Care Unit (NCU) were consecutively enrolled from January 2012 to October 2015. Inclusion criteria were ≥18 years old; brain computerized tomography confirmed ischemic or hemorrhagic stroke; symptoms onset within the previous 14 days; and with both conscious disturbance and endotracheal intubation. Exclusion criteria were mental illness or psychotic disorder; patients who had previous cerebrovascular events with sequela of dysphasia or dyskinesia; eyelid edema; and patients who had received anesthetics, sedatives, or neuromuscular blocking agents within the past 24 h.

Baseline data {#sec2-3}
-------------

Baseline data recorded when patients were admitted to the NCU included age, gender, stroke history and type of stroke (ischemic or hemorrhagic), and brain damage locations (left-hemisphere, right-hemisphere, and brainstem or cerebella).

Coma scoring {#sec2-4}
------------

We recorded the GCS eye-opening component (GCS-E), GCS verbal component (GCS-V), GCS-M, GCS, and SMS on admission and at 24, 48, and 72 h after admission to the NCU. The GCS includes three components, GCS-E, GCS-V, and GCS-M, with a resulting score ranging from 3 (worst) to 15 (best). GCS-V was defined to be 0. SMS was classified into three degrees according to the patients\' motor response (defined as obeys commands = 2; localized pain = 1; and withdrawal to pain or less response = 0). The rater recorded the best motor response from any limb.

Study outcomes {#sec2-5}
--------------

The modified Rankin Scale (mRS) was recorded on the day of discharge from NCU. An unfavorable outcome was defined as an mRS of 5 or 6, while a favorable outcome was an mRS of 0--4. Outcomes at discharge from the NCU, classified as either death or survival, were also recorded.

Statistical analysis {#sec2-6}
--------------------

The SPSS statistical software (version 17.0 for Windows, SPSS Inc., Chicago, IL USA) and the software MedCalc^®^ 15.2.2 (Frank Schoonjans, Mariakerke, Belgium) were used for statistical analysis. Descriptive analyses for continuous variables were used to calculate mean values and standard deviations, whereas frequencies were expressed as percentages.

Prognostic performance was tested by calculation of the receiver operating characteristic (ROC) curve and displayed in the area under the curve (AUC). AUCs between 0.9 and 1.0 were categorized as "outstanding," between 0.8 and 0.9 as "excellent," between 0.7 and 0.8 as "acceptable," and between 0.5 and 0.7 as "poor."\[[@ref6]\] From ROC coordinates, the cutoff values for the aforementioned scores using the score value with the best Youden index (sensitivity + specificity − 1) were identified.\[[@ref7]\] Comparison of the AUCs was performed using the *Z*-test. The positive predictive value and the negative predictive value were also calculated. All hypotheses were constructed as two tailed, and *P* ≤ 0.05 was considered statistically significant.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

Characteristics of total population {#sec2-7}
-----------------------------------

A total of 106 patients were available for final analysis. The mean age of the study sample was 62 ± 12 years. Of 86 (81.1%) were male and 20 (18.9%) were female. A total of 32 (30.2%) had left-hemisphere lesion, 26 (24.5%) had right-hemisphere lesion, and 48 (45.3%) had brainstem or cerebella lesion. The median length of NCU stay was 14 (5--24) days. Forty-one (38.7%) patients died, and 69 (65.1%) patients had a poor prognosis when discharged from NCU.

Predictive performance of different coma scales {#sec2-8}
-----------------------------------------------

Differences of AUCs for GCS, GCS-E, GCS-M, or SMS in predicting death or poor prognosis lacked statistical significance among the four time points within 72 h admitted to NCU, suggesting that evaluation was feasible within 72 h of admission. Comparing GCS-M AUCs with GCS AUCs at the four time points, there was no statistically significant difference in predicting death at 0 and 72 h and in predicting poor prognosis at the four time points, suggesting that GCS-M had similar prognostic power to GCS in assessing death at 0 and 72 h, as well as in assessing poor prognosis within 72 h. The cutoff values for GCS-M were 2 in predicting death (specificity 70% and sensitivity 70%) and 3 in predicting poor prognosis (specificity 89% and sensitivity 74%).

Subgroup analysis according to different brain damage locations {#sec2-9}
---------------------------------------------------------------

**Left-hemisphere lesion**

The AUCs of GCS, GCS-E, GCS-M, or SMS in predicting death or poor prognosis at the four time points had no significant difference, indicating that the predictive power of the above scores at four time points within 72 h admission to NCU were equivalent. Comparing GCS-M AUCs with GCS AUCs at the four time points, there was no significant difference in predicting death and poor prognosis at 0--72 h, indicating that GCS-M had similar predictive performance to GCS in predicting death and poor prognosis for patients with left-hemisphere lesion within 72 h admission to NCU \[[Table 1](#T1){ref-type="table"}\]. The cutoff values for GCS-M were 1 in predicting death (specificity 82% and sensitivity 66.7%) and 3 in predicting poor prognosis (specificity 100% and sensitivity 87.5%; [Table 2](#T2){ref-type="table"}).

###### 

The receiver operating characteristic curve in predicting death and poor prognosis in patients with left-hemisphere lesions

  Parameters       AUC                                                                        
  ---------------- ------------------------ ------------------------ ------------------------ ------------------------
  Death                                                                                       
   GCS             0.700 (0.405--0.908)     0.763 (0.552--0.908)     0.760 (0.566--0.898)     0.827 (0.629--0.946)
   GCS-M           0.700 (0.405--0.908)     0.750 (0.538--0.900)     0.735 (0.539--0.881)     0.804 (0.602--0.932)
   SMS             0.650 (0.358--0.877)     0.607 (0.393--0.794)\*   0.576 (0.380--0.756)\*   0.647 (0.437--0.823)\*
   GCS-E           0.675 (0.381--0.893)     0.721 (0.507--0.880)     0.701 (0.503--0.856)     0.739 (0.530--0.890)
  Poor prognosis                                                                              
   GCS             0.969 (0.718--1.000)     0.955 (0.789--0.998)     0.875 (0.699--0.968)     0.920 (0.744--0.989)
   GCS-M           0.969 (0.718--1.000)     0.958 (0.794--0.999)     0.841 (0.658--0.949)     0.887 (0.701--0.977)
   SMS             0.750 (0.455--0.936)\*   0.667 (0.452--0.841)\*   0.637 (0.439--0.806)\*   0.708 (0.499--0.868)\*
   GCS-E           0.896 (0.619--0.993)     0.806 (0.599--0.935)\*   0.799 (0.609--0.924)     0.830 (0.633--0.948)

Data were present as mean (95% *CI*). GCS: Glasgow Coma Scale; GCS-E: GCS eye-opening component; GCS-M: GCS motor component; SMS: Simplified motor score; AUC: Area under the receiver operator characteristic curve; \*Coma scale whose AUCs were significantly different from AUCs of GCS, with *P*\<0.05; *CI*: Confidence interval.

###### 

Accuracy analysis of GSS-M in predicting death and poor prognosis

  Items                     Youden index   Cut-off points   Sensitivity (%)   Specificity (%)   PPV (%)   NPV (%)
  ------------------------- -------------- ---------------- ----------------- ----------------- --------- ---------
  Left-hemisphere                                                                                         
   Death                                                                                                  
    0 h                     0.350          ≤2               75.0              60.0              42.9      85.7
    24 h                    0.461          ≤3               81.8              64.3              64.3      81.8
    48 h                    0.456          ≤2               75.0              70.6              64.3      80.0
    72 h                    0.490          ≤1               66.7              82.4              66.7      82.4
   Poor prognosis                                                                                         
    0 h                     0.875          ≤2               87.5              100.0             100.0     85.7
    24 h                    0.875          ≤3               87.5              100.0             100.0     81.8
    48 h                    0.681          ≤2               76.5              91.7              92.9      73.3
    72 h                    0.702          ≤2               78.6              91.7              91.7      78.6
  Right-hemisphere                                                                                        
   Death                                                                                                  
    0 h                     0.857          ≤3               100.0             85.7              66.7      100.0
   Poor prognosis                                                                                         
    0 h                     1.000          ≤3               100.0             100.0             100.0     100.0
  Brain stem or cerebella                                                                                 
   Poor prognosis                                                                                         
    0 h                     0.444          ≤4               77.8              66.7              87.5      50.0
    24 h                    0.506          ≤5               90.6              60.0              87.9      66.7
    48 h                    0.515          ≤5               87.9              63.6              87.9      63.6
    72 h                    0.598          ≤5               87.1              72.7              90.0      66.7

GCS-M: GCS motor component; PPV: Positive predictive value; NPV: Negative predictive value.

**Right-hemisphere lesion**

The AUCs of GCS, GCS-M, GCS-E, and SMS in predicting death and unfavorable outcome were entirely maximal at 0 h and had significant differences with the other three time points, implying that 0 h was the best evaluation time point. No significant difference was observed between the AUCs of GCS-M and GCS in predicting outcomes at 0 h, which meant that the GCS-M and GCS had comparable prognostic value in predicting death and unfavorable outcome for patients suffering right-hemisphere lesion \[[Table 3](#T3){ref-type="table"}\]. The cutoff values for the GCS-M were 3 in predicting death (specificity 87.5% and sensitivity 100%) and unfavorable outcome (specificity 100% and sensitivity 100%; [Table 2](#T2){ref-type="table"}).

###### 

The receiver operating characteristic curve in predicting death and poor prognosis in patients with right-hemisphere lesions

  Parameters       AUC                                                                    
  ---------------- ------------------------ ---------------------- ---------------------- ------------------------
  Death                                                                                   
   GCS             0.964 (0.612--1.000)     0.714 (0.472--0.891)   0.695 (0.465--0.871)   0.730 (0.511--0.889)
   GCS-M           0.964 (0.612--1.000)     0.615 (0.375--0.821)   0.676 (0.446--0.857)   0.704 (0.484--0.871)
   SMS             0.643 (0.280--0.913)\*   0.577 (0.339--0.791)   0.600 (0.372--0.800)   0.600 (0.382--0.792)
   GCS-E           0.929 (0.565--1.000)     0.769 (0.530--0.925)   0.638 (0.408--0.829)   0.693 (0.473--0.863)
  Poor prognosis                                                                          
   GCS             1.000 (0.664--1.000)     0.724 (0.482--0.897)   0.723 (0.494--0.890)   0.793 (0.580--0.929)
   GCS-M           1.000 (0.664--1.000)     0.740 (0.498--0.907)   0.772 (0.546--0.922)   0.825 (0.616--0.948)
   SMS             0.667 (0.299--0.925)\*   0.583 (0.345--0.796)   0.607 (0.379--0.806)   0.607 (0.389--0.798)\*
   GCS-E           1.000 (0.664--1.000)     0.656 (0.414--0.851)   0.612 (0.383--0.809)   0.671 (0.452--0.847)

Data were present as mean (95% *CI*); GCS: Glasgow Coma Scale; GCS-E: GCS eye-opening component; GCS-M: GCS motor component; SMS: Simplified motor score; AUC: Area under the receiver operator characteristic curve; \*Coma scale with AUCs that were significantly different from AUCs of GCS, with *P*\<0.05; *CI*: Confidence interval.

**Brainstem or cerebella lesion**

The AUCs in predicting mortality for GCS-E, GCS-M, and SMS were all \<0.7, with no further analysis made. Each coma scale was equivalent in predicting unfavorable outcome within 72 h. No significant difference was observed between the AUCs of GCS-M and GCS in predicting unfavorable prognosis at four time points, demonstrating that the GCS-M was comparable to the GCS in prognostic power in predicting unfavorable prognosis within 72 h of admission to NCU \[[Table 4](#T4){ref-type="table"}\]. The cutoff values for the GCS-M in predicting poor prognosis were 4 or 5 (specificity 60--73% and sensitivity 78--91%), but the specificity and sensitivity were unsatisfactory \[[Table 2](#T2){ref-type="table"}\].

###### 

The receiver operating characteristic curve in predicting death and poor prognosis in patients with brain stem or cerebella lesions

  Parameters       AUC                                                                        
  ---------------- ------------------------ ------------------------ ------------------------ ------------------------
  Death                                                                                       
   GCS             0.651 (0.432--0.832)     0.702 (0.541--0.833)     0.711 (0.555--0.837)     0.721 (0.562--0.848)
   GCS-M           0.676 (0.457--0.851)     0.660 (0.498--0.799)     0.660 (0.502--0.796)     0.683 (0.522--0.818)
   SMS             0.576 (0.359--0.773)\*   0.560 (0.398--0.712)\*   0.612 (0.453--0.755)\*   0.617 (0.455--0.763)\*
   GCS-E           0.622 (0.403--0.810)     0.671 (0.509--0.808)     0.725 (0.569--0.848)     0.727 (0.568--0.853)
  Poor prognosis                                                                              
   GCS             0.704 (0.484--0.871)     0.730 (0.571--0.855)     0.753 (0.600--0.871)     0.820 (0.670--0.921)
   GCS-M           0.727 (0.508--0.887)     0.752 (0.594--0.872)     0.731 (0.577--0.854)     0.801 (0.649--0.908)
   SMS             0.741 (0.523--0.896)     0.734 (0.576--0.859)     0.747 (0.593--0.865)     0.790 (0.637--0.900)
   GCS-E           0.639 (0.419--0.823)     0.647 (0.484--0.788)     0.730 (0.575--0.853)     0.760 (0.603--0.878)

Data were present as mean (95% *CI*); GCS: Glasgow Coma Scale; GCS-E: GCS eye-opening component; GCS-M: GCS motor component; SMS: Simplified motor score; AUC: Area under the receiver operator characteristic curve; \*Coma scale with AUCs that were significantly different from AUCs of GCS, with *P*\<0.05; *CI*: Confidence interval.

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

The study found that the GCS-M approached the same test performance as the GCS for the prediction of death and unfavorable prognosis in acute severe cerebral vascular disease patients with intubation. The timing of the implementation of the evaluation within 72 h of admission to NCU was without distinction. The GCS-M had a similar predictive performance to the GCS in predicting death and poor prognosis for patients with left-hemisphere or right-hemisphere lesions, the cutoff points of which were 2 or 3 (specificity 60--100% and sensitivity 75--100%). The same was true for the GCS-M in predicting poor prognosis for patients with brainstem or cerebella lesions, and the cutoff points were 4 or 5 (specificity 60--73% and sensitivity 78--91%). However, the performance of the GCS-M in predicting death for patients with brainstem or cerebella lesions was unsatisfactory. Compared to the GCS, SMS performed poorly in general.

Accurate and complete GCS scores are difficult to obtain in many situations, for example, if the patient is intubated or has excessive swelling of the eyelids, thus impeding the performance of the GCS.\[[@ref8]\] Recently, an international questionnaire-based survey including 48 countries showed that the method for recording GCS-V in intubated patients lacked standardization, where 67% would record the designation "T," 17% assign a score of 1 (V1), and 15% assign a score of 0 (V0), leading to great variation in inter-rater reliability.\[[@ref9]\] In contrast, a simplified assessment system could circumvent the above-mentioned issues and thus would be easier to operate while also more practical in clinical practice.

Previous studies have shown that the GCS-M could accurately assess the prognosis in TBI and cardiac arrest patients.\[[@ref10][@ref11]\] Our results showed that the GCS-M was a predictor of death or unfavorable outcome in intubated acute severe cerebral vascular disease patients (AUC 0.730 and 0.827), while its prognostic power was equivalent to that of the GCS. This was consistent with the Handschu *et al*.,\[[@ref12]\] study (90 patients), in which the GCS-M had similar prognostic strength to the GCS in predicting morality in intubated acute severe cerebral vascular disease patients, though the AUCs were smaller than ours (GCS: 0.69 and GCS-M: 0.64). Hence, when the total GCS cannot be realized, we can adopt the GCS-M to assess coma and prognosis.

The brain damage locations may affect the prognostic performance of coma scales. For example, left-hemisphere and brainstem or cerebella lesions can influence the assessment of GCS-V. Thus, we conducted a stratified analysis of coma scales for patients with impaired left-hemisphere, right-hemisphere, and brainstem or cerebella. The results showed that the GCS-M has a similar predictive performance to the GCS in predicting outcomes for patients with left-hemisphere or right-hemisphere lesions and brainstem or cerebella lesions, except for predicting death in patients with brainstem or cerebella lesions. This finding could be explained by the possibility that quadriplegia accounted for a large proportion (65%) of patients with brainstem or cerebella lesions, thus shadowing the performance of GCS-M. Therefore, we should take brain damage locations into account when employing GCS-M to assess prognosis in intubated acute severe cerebral vascular disease patients, as it would be more accurate and reliable when applied in patients with hemisphere lesions; however, caution must be taken if evaluated patients had brainstem or cerebella lesions.

In 2005, Gill *et al*.\[[@ref3]\] first proposed SMS and concluded that SMS demonstrated a test performance similar to the total GCS score for the prediction of in-hospital mortality in TBI (AUC: 0.878 vs.0.906). However, SMS did not show any advantage in this study (AUC \<0.700). This may be because SMS is too simple to reflect the complexity of neurologic deficits in acute severe cerebral vascular disease patients. Therefore, the SMS was not recommended for the evaluation of acute severe cerebral vascular disease patients with intubation.

There are two main limitations in this study. First, the study was a retrospective analysis of a prospectively collected database and thus lacked a more rigorous design. Second, it was a single-center study and had a small sample size. A larger sample from a multicenter clinical study is needed, and our results should only be used as a reference for clinicians.

In conclusion, the study suggested that the GCS-M can accurately predict the prognosis of intubated acute severe cerebral vascular disease patients as with the GCS. However, this was not for the patients with brainstem or cerebella lesions.
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